Skip to main content
. 2021 Mar 26;13(7):1534. doi: 10.3390/cancers13071534
AR androgen receptor
AR-V7 an AR splice variant
ADT androgen deprivation therapy
ARE androgen response element
Bic bicalutamide
CAF cancer-associated fibroblasts
CRPC castration-resistant prostate cancer
CTC circulating tumor cells
CSC cancer stem cell
DRPC drug resistance Pca
DHT dihydrotestosterone
EGFR epidermal growth factor receptor
Enz enzalutamide
EMT epithelial-mesenchymal transition
GR glucocorticoid receptor
LCoR ligand-dependent co-repressor
mCRPC metastatic CRPC
NLS nuclear localization signal
NEPC neuroendocrine prostate cancer
LBD ligand-binding domain
NTD amino-terminal domain
ODM darolutamide
Pca prostate cancer
PSA prostate specific antigen
SFK Src family of kinases